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Edited by Gianni CesareniAbstract CTRP1, a member of the CTRP superfamily, con-
sists of an N-terminal signal peptide sequence followed by a var-
iable region, a collagen repeat domain, and a C-terminal
globular domain. CTRP1 is expressed at high levels in adipose
tissues of LPS-stimulated Sprague-Dawley rats. The LPS-
induced increase in CTRP1 gene expression was found to be
mediated by TNF-a and IL-1b. Also, a high level of expression
of CTRP1 mRNA was observed in adipose tissues of Zucker dia-
betic fatty (fa/fa) rats, compared to Sprague-Dawley rats in the
absence of LPS stimulation. These ﬁndings indicate that CTRP1
expression may be associated with a low-grade chronic inﬂam-
mation status in adipose tissues.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Adipose tissue is the major organ for lipid storage and plays
important roles in fatty acid metabolism and glucose homeo-
stasis. Obesity, characterized by increased body fat stores
resulting from an imbalance between energy intake and energy
expenditure, is associated with many diseases including cardio-
vascular disease, hypertension, and type II diabetes [1,2]. Re-
cently, adipose tissue has been classiﬁed as an endocrine
organ because it secrets adipokines, adipose tissue secreting
hormones, including TNF-a [3,4], leptin [5,6], adiponectin
[7–9] and resistin [10], which participate in the regulation of di-Abbreviations: CTRP, complement-C1q TNF-related protein; LPS,
lipopolysaccharide; SDS–PAGE, sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis; IPTG, isopropyl b-D-1-thiogalactopyrano-
side
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[11,12] and immune responses [13].
Adiponectin has structural features that include an N-ter-
minal collagen-like domain and a C-terminal C1q globular
domain [14], which has a 3D structure similar to TNF-a
although their primary structures show no signiﬁcant homol-
ogy [15]. Therefore, a protein containing this domain is
called complement-C1q TNF-related protein (CTRP). There
are eight members in the CTRP superfamily, including
adiponectin. Several years ago, CTRP2 and CTRP3 were re-
ported. CTRP3 has been reported to be CORS26 (collage-
nous repeat-containing sequence of 26-kDa protein), which
encodes a secretory protein. It is expressed at high levels
in condensed prechondrocytic cells of cartilage primordia
and developing cartilages. This suggests that CORS26 plays
an important role in skeletal development [16] and in regu-
lating both chondrogenesis and cartilage development [17].
CTRP2 is known to induce the phosphorylation of AMP-
activated protein kinase, resulting in increased glycogen
accumulation and fatty acid oxidation. This suggests that
CTRP2 may compensate for the function of adiponectin
[18]. CTRP1 has recently been reported to be expressed in
the vascular wall tissues and to inhibit collagen-induced
platelet aggregation by blocking von Willebrand factor bind-
ing to collagen [19]. In the present study, we report on
the characterization of CTRP1, a member of the CTRP
superfamily.2. Materials and methods
2.1. Cloning of CTRP1 and plasmid construction
The following primer pairs for human CTRP1 were designed
according to AF329840 (sense, cggaattcatgggctcccgtggacag; antisense,
ccctcgagctagggctcggtggcgtg). For the rat CTRP1 primer design, the ex-
pressed sequence tag database (EST) and the genome database (NCBI)
was searched with the mouse CTRP1 cDNA sequence as a query. As a
result of the search, the following mouse CTRP1 primer pairs were
used for rat CTRP1 cloning (sense, cggaattcatgggctcctgtgcacag; anti-
sense, ccctcgagctagggctcagaggctgg) since the region of the primer pairs
matched the mouse sequences. Plasmids harboring a full-length of
human, mouse, rat CTRP1 cDNA in pBluescript named as pBKS-
hCTRP1, pBKS-mCTRP1, and pBKS-rCTRP1, respectively.blished by Elsevier B.V. All rights reserved.
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For the production of recombinant human CTRP1 from E. coli,
CTRP1 cDNA without a signal sequence was ligated into the pET28a
vector (Novagen, Madison, WI). The resulting pET28a-hCTRP1 was
used to transform E. coli strain BL21(kDE3). The N-terminal His-
tagged CTRP1 was induced by treatment with 0.5 mM of isopropyl
b-D-1-thiogalactopyranoside (IPTG). The resulting bacterial cells were
precipitated and suspended in lysis buﬀer (50 mM Tris–HCl, pH 8.0,
0.2% Triton X-100) and sonicated. The suspended buﬀer was centri-
fuged and the pellet was washed with lysis buﬀer. The pellet, contain-
ing the inclusion body, was dissolved in solubilization buﬀer (7 M
guanidine-HCl, 50 mM Tris–HCl, pH 8.0). The dissolved solution
was slowly added to 50 volumes of refolding buﬀer (550 mM guani-
dine, 440 mM L-arginine, 55 mM Tris–HCl, 21 mM NaCl, 0.88 mM
KCl, 1 mM EDTA, 2 mM GSH, 0.2 mM GSSG, pH 8.2), incubated
for 24 h, concentrated to a volume of 50 ml, and dialyzed against
20 mM Tris–HCl, pH 8.0. The dialyzed solution was loaded onto a
Q-Sepharose Fast Flow column (Pharmacia Biotech, Sweden), washed
with washing buﬀer (20 mM Tris–HCl, pH 8.0, 50 mM NaCl) and the
bound recombinant CTRP1 was eluted with elution buﬀer (20 mM
Tris–HCl, pH 8.0, 0.5 M NaCl). The pooled fractions were dialyzed
against 20 mM Tris–HCl and stored at 70 C until used. For the pro-
duction of recombinant human CTRP1 from insect cells, a fragment of
cDNA encoding the His-tagged CTRP1 protein was obtained from the
pET28a-hCTRP1 vector and ligated to pBacPAK9 (Clontech, Palo
Alto, CA). A recombinant baculovirus was prepared by recombination
between pBacPAK9-hCTRP1 and linearized viral DNA (Clontech)
according to the manufacturer’s instructions. Virus stocks were gener-
ated and plaque-puriﬁed. For large scale expression, High FiveTM cells
(Invitrogen) in Grace insect medium were grown in roller bottles to a
density of 106 cells per ml and then infected with the recombinant bac-
ulovirus at a multiplicity of infection of 5. The baculovirus infected in-
sect cells were harvested, resuspended in lysis buﬀer (50 mM
NaH2PO4, 300 mM NaCl, 1% NP-40, 10 mM imidazole, pH 8.0),
and disrupted by sonication. The supernatants, after clariﬁcation by
centrifugation at 12000 · g for 30 min, were loaded onto a Ni-NTA
column and washed with buﬀer W (50 mM NaH2PO4, 300 mM NaCl,
20 mM imidazole, pH 8.0). The bound CTRP1 was eluted with buﬀer
E (50 mM NaH2PO4, 300 mM NaCl, 400 mM imidazole, pH 8.0) and
the pooled proteins were dialyzed against phosphate buﬀered saline
(PBS).2.3. Production of rabbit anti-CTRP1 polyclonal antibody
The human CTRP1 cDNA encoding collagen repeated domain was
introduced into pET28a bacterial expression vector (Novagen), which
is transformed into E. coli BL21 (kDE3) strain. The expression of the
collagen domain of CTRP1 was induced by the addition of 1 mM of
isopropyl b-thiogalactopyranoside. The collagen domain of CTRP1
was expressed as a form of inclusion body and puriﬁed according to
the full-length protein folding protocol. One hundred micrograms of
CTRP1 was mixed with Freund’s complete adjuvant and then subcu-
taneously injected into rabbits. The animals were boosted with the
same amount of protein mixed with Freund’s incomplete adjuvant
every month, and blood was collected 1 week after the last boost. To
test the speciﬁcity of the antibody, human CTRP1 cDNA was sub-
cloned into FLAG-tagging vector pCMV-Tag2b (Stratagene, La Jolla,
CA) and the resulting expression vector was transfected into 293 cells,
and the cell lysates were subjected to Western blot analysis using rabbit
anti-CTRP1 serum and anti-FLAG antibody.
2.4. Western blot analysis
The puriﬁed CTRP1 was separated on a 12% SDS–polyacrylamide
gel, and transferred to a PVDF membrane (Millipore, Marlborough,
MA). The membrane was blocked with 5% skim milk in TBS
(50 mM Tris–HCl, pH 7.5, 150 mM NaCl) for 1 h, and then incubated
for 2 h with rabbit anti-CTRP1 polyclonal antibody or anti-FLAG
antibody. After washing three times with TBST (0.05% Tween20,
50 mM Tris–HCl, pH 7.5, 150 mM NaCl) for 15 min, the membrane
was incubated with the anti-rabbit IgG secondary antibody conjugated
with horse-radish peroxidase or the anti-mouse IgG secondary anti-
body conjugated with horse-radish peroxidase. The signal was detected
using the Amersham ECL system (Amersham Pharmacia Biotech,
Arlington Heights, IL) and analyzed by LAS3000 luminescent image
analyzer (Fujiﬁlm, Tokyo).2.5. Animals
Male Sprague-Dawley (SD) rats (Dae Han Bio Link) 8–12 weeks of
age were allowed to acclimate to handling for four days under stan-
dard conditions of 12 h of light per day. Food and water were provided
ad libitum. Male Zucker diabetic fatty (ZDF) and lean control rats 4–
12 weeks of age were obtained from the Korea Research Institute of
Bioscience and Biotechnology (KRIBB).
2.6. Preparation of mature adipocytes and culture of human adipocyte
cell line SGBS
Mature adipocytes were prepared from adipose tissue using a previ-
ously described method [20]. The epididymal adipose depots from male
Sprague-Dawley (SD) rats aged 8–10 weeks were quickly removed. The
epididymal fat depots were washed with PBS, cut into 2 mm pieces,
and then mixed with 10 ml of collagenase buﬀer (2 mg/ml, type II; Sigma).
After incubating at 37 C for 50 min on a rocking platform shaker, the
15 ml conical tubes containing digested tissues were centrifuged at
500 rpm for 2 min to remove preadipocytes. The ﬂoating mature adi-
pocytes were washed twice with 10 volumes of DMEM supplemented
with 10% FBS to wash collagenase and cultured in DMEM with 10%
FBS or without 10% FBS for 1 day. The preadipocytes were plated in
6-well plates and cultured until reaching conﬂuence. Diﬀerentiation
was induced by the addition of medium supplemented 0.5 mM isobu-
tylmethylxanthine, 2 lM dexamethasone, and 1.7 lM of insulin. The
induction medium was removed two days after the incubation. After
the additional two days of incubation in DMEM supplemented with
10% FBS and 1.7 lM of insulin, the medium was changed at 2 day
intervals with DMEM supplemented with 10% FBS. The total RNA
was isolated at two day intervals. The human adipocyte cell line SGBS
was a generous gift from Dr. Wabitsch, University of Ulm, Germany.
The culturing of the SGBS cells and their induction into mature human
adipocytes were performed exactly as previously published [21].
Brieﬂy, SGBS preadipocytes were maintained with DMEM/F12 (1:1)
medium containing 10% (v/v) fetal bovine serum and antibiotics (pen-
icillin/streptomycin). To induce adipogenic diﬀerentiation, SGBS cells
were washed three times with PBS and cultured in DMEM/F12 (1:1)
medium supplemented with 10 lg/ml transferrin, 10 nM insulin,
2 lM rosiglitazone, 500 lM isobutylmethylxanthine, and 25 nM dexa-
methasone for four days. The medium was changed with DMEM/F12
(1:1) medium supplemented with 10 lg/ml transferrin, 10 nM insulin,
and 1 lM dexamethasone every three days. Diﬀerentiation into adipo-
cytes was visualized under the microscope from the accumulation of
lipid droplets. On day 12–14 after the induction of diﬀerentiation,
TNF-a was treated for the indicated time periods.
2.7. Northern blot analysis
SD rats were injected intraperitoneally with lipopolysaccharide
(LPS) (2.5 mg/kg) or PBS or TNF-a (8 lg/kg) and/or IL-1b (16 lg/
kg), and then killed by decapitation at 2 h and 6 h after LPS adminis-
tration or 4 h after TNF-a and/or IL-1b administration. Epididymal
adipose depots were removed for total RNA isolation. Total RNA
from adipose tissue was prepared using RNAzol B (TEL-TEST,
Friendwoods, TX), electrophoresed in a 3% formaldehyde gel and
transferred to a nylon membrane using a turbo blotter (Schleicher &
Schuell, Keene, NH). To estimate the amount of RNA loading, the
transferred membrane was photographed. 32P-labeled cDNA probes
were prepared from the coding region of mCTRP1 cDNA using a High
Prime DNA labeling kit (Roche Applied Science, Mannheim, Ger-
many) and used in the sequential hybridizations. After each hybridiza-
tion, the membrane was washed with 0.1· SSC, 0.05% SDS at 50 C
and exposed to X-ray ﬁlm for 6–18 h at 80 C with an intensifying
screen. The membrane was thoroughly stripped after hybridization
with each probe by boiling in 0.01% SDS for 5 min.3. Results
3.1. Cloning of CTRP1 cDNA and the deduced amino acid
sequences
In order to identify CTRP superfamily members, we
searched the National Center for Biotechnology Information
(NCBI) database with the adiponectin cDNA sequence since
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domain. As a result, 7 members of the CTRP superfamily orig-
inally named CTRP1, 2, 3, 4, 5, 6 and 7 were found. The focus
of the present study was on CTRP1. The primer pairs for the
RT-PCR cloning of CTRP1 were designed according to the
GenBank sequence. The deduced amino acid sequence of each
species was compared with adiponectin sequence. The collagen
repeat domain of CTRP1 contains 14 perfect Gly X Pro or
Gly-X-Y repeats while adiponectin contains 22 repeats
(Fig. 1A). Four conserved residues that are important in theA
B C
Fig. 1. Structural features of the CTRP family. (A) Alignment of the amino ac
is italicized. The collagen repeat domain is boxed. Four conserved residues th
indicated by black downward arrows. Asterisks indicate matched amino acid
into C-terminal FLAG-tagging vector, pCMV-Tag4A and stable transfect
subjected to Western blot analysis using anti-FLAG monoclonal antibody. (
CTRP1 was separated by SDS–PAGE and Western blot analysis was perfor
DTT, CTRP1 formed a homodimer, a homotrimer, a homomultimer.packing of the hydrophobic core of adiponectin [12,15] are
well conserved in CTRP1.
3.2. Characterization of CTRP1 protein
Human CTRP1 cDNA encoding a full-length protein with
putative signal peptide was subcloned into pCMV-tag4A vec-
tor to express the C-terminal FLAG-tagged CTRP1 protein.
The resulting expression plasmid was transfected into COS-7
cells, and stable transfectants were selected. The culture super-
natants from stable clones were subjected to Western blotid sequences of CTRP1 from three species. The signal peptide sequence
at are important in the packing of hydrophobic core of adiponectin are
s among the species. (B) A full-length cDNA of CTRP1 was subcloned
ants were selected. The culture supernatants of stables clones were
C) CTRP1 proteins were expressed in E. coli and insect cells. Puriﬁed
med using rabbit anti-CTRP1 polyclonal antibody. In the absence of
AB
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into the culture supernatants. The secreted CTRP1 protein
was detected at a size of 35 kDa.
Human CTRP1 cDNA encoding a full-length protein elimi-
nating a putative signal peptide was subcloned into a pET28a
vector and transformed into Escherichia coli. The synthesis of
CTRP1 was induced by treatment with IPTG. For the expres-
sion of CTRP1 in the insect cells, CTRP1 cDNA was sub-
cloned into a pBacPak9 and puriﬁed CTRP1 proteins from
each system were analyzed by means of Western blot assay
with rabbit polyclonal anti-CTRP1 antibody. When the
CTRP1 protein was separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE), a 35 kDa
protein, corresponding to the position of a monomer, was ob-
served in the presence of DTT and a dimer, trimer, multimeric
complex were detected under non-reducing condition
(Fig. 1B), indicating that CTRP1 forms homooligomers under
natural conditions.Fig. 2. Expression pattern of CTRP1 mRNA in various tissues. (A)
SD rats were injected intraperitoneally with LPS (2.5 mg/kg). Various
tissues were removed 6 h after the LPS administration and subjected to
total RNA isolation. The blot was probed with rat CTRP1 cDNA.
Two mRNA species with sizes of 3.3 kb and 1.8 kb were expressed only
in the LPS-treated epididymal fat depot. The transferred blot was
photographed and used as an equal loading control. (B) Time kinetics
of CTRP1 mRNA expression. SD rats were injected intraperitoneally
with LPS (2.5 mg/kg). The total RNA was isolated from epididymal
adipose depot at the indicated times after LPS administration. The b-
actin probe was used for an equal loading control.3.3. Patterns of CTRP1 mRNA expression in various SD rat
tissues
To examine the tissue distribution of CTRP1 mRNA expres-
sion, Northern blot analysis was performed using various SD
rat tissues, including liver, spleen, muscle, fat, heart, and kid-
ney. Interestingly, no band was observed in various tissues.
We then injected LPS into SD rats because LPS is known to
induce hyperglycemia and insulin resistance [22,23] and expres-
sion of resistin in adipocytes [24]. At 6 h after an intraperito-
neal injection of LPS, two mRNA species with sizes of
3.3 kb and 1.8 kb were highly induced only in the LPS-treated
epididymal fat depot, but were not detected in the normal epi-
didymal fat depot (Fig. 2A). Time kinetics for CTRP1 mRNA
induction after LPS administration was next determined. Epi-
didymal fat was obtained from SD rats at the indicated time
points after intraperitoneal injection of LPS. The expression
of CTRP1 mRNA was induced 6 h after LPS administration
and sustained until 24 h (Fig. 2B).3.4. TNF-a and IL-1b-mediated induction of CTRP1 mRNA
expression
In order to determine whether LPS can directly activate adi-
pocytes to induce CTRP1 expression in vitro, mature adipo-
cytes were isolated from adipose tissue of SD rats and
treated with LPS. LPS treatment did not cause the induction
of CTRP1 mRNA (Fig. 3A). Surprisingly, CTRP1 mRNA
was highly expressed in isolated mature adipocytes although
we did not observe the CTRP1 band in adipose tissue by
Northern blot analysis. Therefore, we hypothesized that a
component of serum could induce the expression of CTRP1
mRNA, since cultures of mature adipocytes was performed
in DMEM containing 10% fetal bovine serum. To test this pos-
sibility, mature adipocytes were incubated in serum-free med-
ium. CTRP1 mRNA was also highly expressed in mature
adipocytes cultured in serum-free medium (Fig. 3B). These
ﬁndings suggest that the CTRP1 gene is induced by distur-
bance of adipose tissue in vitro in addition to the LPS treat-
ment in vivo.
LPS is a powerful inducer of proinﬂammatory cytokines
including TNF-a and IL-1b. To examine whether TNF-a
and IL-1b mimic the LPS-mediated induction of CTRP1
mRNA in vivo, TNF-a and IL-1b were injected intraperitone-ally into SD rats. Total RNA was obtained from epididymal
fat depots 4 h after TNF-a and IL-1b administration and
Northern blot analysis was performed. The expression of
CTRP1 mRNA was highly induced in epididymal fat depots
of SD rats that had been administered LPS or IL-1b or IL-
1b and TNF-a. The level of IL-1b-inducible CTRP1 mRNA
expression was enhanced by the cotreatment of TNF-a
(Fig. 3C). The eﬀect of TNF-a on CTRP1 mRNA expression
was also examined in the human adipocyte cell line SGBS.
When diﬀerentiated SGBS adipocytes were treated with
TNF-a, CTRP1 mRNA expression and proteins were highly
increased whereas adiponectin mRNA expression was de-
creased (Fig. 3D).
3.5. Diﬀerentiation-dependent expression of CTRP1 mRNA
We next examined the expression of CTRP1 mRNA during
adipocyte diﬀerentiation, since CTRP1 mRNA was expressed
in adipose tissues. Preadipocytes were isolated from epididy-
mal fat depots of SD rats and subjected to diﬀerentiation.
CTRP1 mRNA was expressed in preadipocytes and its expres-
sion was increased on day 4 after the induction of diﬀerentia-
tion and plateaued at day 10 (Fig. 4). Adiponectin and aP2
were not expressed before the induction of diﬀerentiation.
The fold induction of CTRP1 between day 2 and day 4 was
similar to that of aP2. This ﬁnding suggests that CTRP1 might
play a role in preadipocytes as well as mature adipocytes.
3.6. CTRP1 mRNA expression in ZDF rats
In order to determine whether CTRP1 is related to obesity
or diabetes, we examined CTRP1 expression levels in both
ZDF (fa/fa) rats and ZDF (fa/fa) rats that had been adminis-
A B
C D
Fig. 3. CTRP1 mRNA expression in mature adipocytes. (A) Mature
adipocytes were prepared from epididymal adipose depots of two SD
rats. The prepared mature adipocytes were cultured in the presence of
LPS (10 lg/ml) for 1 day and the total RNA was then isolated.
Northern blot analysis was performed with rat CTRP1 cDNA. (B) The
mature adipocytes were incubated in the presence or absence of 10%
fetal bovine serum in DMEM medium for 1 day. Northern blot
analysis was performed with rat CTRP1 cDNA or rat adiponectin
cDNA probe. SD mature, fresh mature adipocytes; SD mature D10,
mature adipocytes cultured in DMEM containing 10% fetal bovine
serum; SD mature D0, mature adipocytes cultured in DMEM without
10% fetal bovine serum. (C) Epididymal fat depots were obtained from
SD rats 4 h after the administration of PBS, IL-1b (16 lg/kg), TNF-a
(8 lg/kg), and LPS (2.5 mg/kg). Northern blot analysis was performed
with rat CTRP1 cDNA. One rat per group was sacriﬁced. The data
shown are representative of one of two independent experiments. The
transferred blot was photographed and used as an equal loading
control. (D) Diﬀerentiated SGBS adipocytes were treated with 10 ng/
ml of TNF-a for two days. The culture supernatants were subjected to
Western blot analysis using anti-CTRP1 polyclonal antibody and
Northern blot analysis was performed with human CTRP1 cDNA.
The transferred blot was photographed and used as an equal loading
control.
Fig. 4. CTRP1 expression in diﬀerentiated adipocytes. Preadipocytes
obtained from epididymal adipose depots of SD rat were cultured and
diﬀerentiated. The total RNA was isolated at the indicated day after
the induction of diﬀerentiation. Northern blot analysis was subse-
quently performed with CTRP1, adiponectin, aP2, and LPL cDNA
probe. The expression of CTRP1 mRNA was increased on day 4 after
the induction of diﬀerentiation. The transferred blot was photo-
graphed and used as an equal loading control.
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tissues, including epididymal fat tissues, were used in the prep-
aration of total RNA. Surprisingly, CTRP1 mRNA was highly
expressed in epididymal fat tissue without the administration
of LPS, but not in other tissues (Fig. 5A). This ﬁnding
prompted us to examine CTRP1 expression in lean control
and obese ZDF rats. Therefore, we prepared total RNA from
epididymal adipose depots of lean ZDF (Fa/Fa), lean ZDF
(Fa/fa), and obese ZDF (fa/fa) rats and Northern blot analyses
were performed. CTRP1 mRNA was highly expressed in obese
ZDF (fa/fa) rats but not in lean controls. The serum levels of
adiponectin as an obesity marker were evaluated by Western
blot analysis. The obese ZDF (fa/fa) rats showed decreasedserum levels of adiponectin while CTRP1 mRNA was highly
expressed in epididymal fat depots (Fig. 5B). These results
indicate that CTRP1 may be associated with obesity and/or
diabetes. We next examined the age-dependent expression level
of CTRP1 in ZDF (fa/fa) rats since the development of diabe-
tes in ZDF rats is age-dependent. No diﬀerence was found be-
tween lean ZDF (Fa/fa) and obese ZDF (fa/fa) at one month
after birth (Fig. 5C). Starting 2 months after birth, CTRP1
expression was decreased in lean ZDF (Fa/fa) rats and sus-
tained in obese ZDF (fa/fa) rats. The diﬀerence of CTRP1
expression level between obese ZDF and lean ZDF rats was
similar in 2-month-old and 4-month-old ZDF rats. Triglycer-
ide and fasting glucose concentrations were measured to exam-
ine the physiological status of ZDF rats at the indicated ages
(Fig. 5D). Although the increase in CTRP1 expression was ob-
served in 2-month-old obese ZDF rats, the fasting glucose level
was increased in 4-month-old obese ZDF rats whereas the tri-
glyceride level was increased in 2-month-old obese ZDF rats,
indicating that CTRP1 expression may precede the develop-
ment of diabetes.4. Discussion
We provide the ﬁrst evidence to show that CTRP1 may play
an important role as an adipokine. The conclusion is based on
the following results. First, it contains a signal peptide se-
quence for the secretion like other adipokines and is expressed
in adipocytes. Second, CTRP1 mRNA expression in the epi-
didymal adipose depot of obese ZDF (fa/fa) rats showed a sig-
niﬁcant increase compared with ZDF (Fa/Fa), ZDF (Fa/fa),
and SD rats. In addition to the rat obese model, CTRP1
expression was also increased in the epididymal adipose depot
compared with lean controls in ob/ob and db/db mouse models
(data not shown), consistent with a previous report [18]. These
AB
C
D
Fig. 5. Expression pattern of CTRP1 mRNA in ZDF rats. (A) Male ZDF (fa/fa) rats were administered LPS (2.5 mg/kg). Total RNA was isolated
from various tissues 6 h after LPS injection. Northern blot analysis was then performed. CTRP1 mRNA was expressed in epididymal adipose depots
of both of control and LPS-injected rat. (B) Total RNA was isolated from the epididymal adipose depots of male ZDF (Fa/Fa), ZDF (Fa/fa), and
ZDF (fa/fa) rats. Two rats per group were sacriﬁced. Northern blot analysis was performed. Obese ZDF (fa/fa) rats showed a high expression of
CTRP1 mRNA. The serum obtained from each group was subjected to Western blot analysis using the rabbit anti-adiponectin antibody. (C) Total
RNA was isolated from obese ZDF (fa/fa) rats and lean ZDF (Fa/fa) rats one month, two months and four months after birth. Northern blot
analysis was performed. The transferred blot was photographed and used as an equal loading control. (D) Blood was isolated from obese ZDF (fa/fa)
rats and lean ZDF (Fa/fa) rats one month, two months and four months after birth. Triglyceride and fasting glucose concentration was measured. All
values are represented as the means ± S.E.M. of duplicates.
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diabetes or adipocyte metabolism. It is also necessary to exam-
ine the expression of CTRP1 in other fat depots because adi-
pose tissues show regional diﬀerences in morphology,
metabolism and physiologic response.
The level of CTRP1 gene expression in the epididymal adi-
pose depot of SD rats was low, but highly induced by the
administration of LPS. However, we observed that CTRP1
was highly expressed in isolated and subsequent in vitro cul-
ture of primary adipocytes of normal SD rats. To prove
whether some serum components are involved in this phenom-
enon, we cultured primary adipocytes in the presence or ab-
sence of 10% serum, but we failed to show that a serum
component is involved in the induction of CTRP1 (Fig. 3C
and D). There is an important report to explain our observa-
tion. The disturbance of mouse adipose tissues during the iso-
lation of adipocytes induces TNF-a and IL-6 production and
the standard isolation procedure triggers the reprogramming
of gene expression in primary adipocytes [25]. On the basis
of this fact, it is possible that basal CTRP1 expression may
be induced by TNF-a, which is produced during isolation
and subsequent culture of primary adipocytes of SD rats.CTRP1 gene expression in the epididymal adipose depot of
SD rats was highly induced by the administration of LPS, a
potent inﬂammatory mediator, and level of CTRP1 gene
induction was comparable with the basal level of CTRP1 gene
expression in obese ZDF rats, suggesting that CTRP1 expres-
sion levels may be linked to the inﬂammatory status of adipose
tissues. Obesity has recently been classiﬁed as a type of low-
grade chronic inﬂammation [26] because a higher mass of adi-
pose tissue secretes increased amounts of proinﬂammatory
cytokines including IL-1, IL-6, TNF-a, and acute phase pro-
teins [27,28] and macrophages inﬁltrate the fat mass in obese
individuals [29]. Therefore it is conceivable that obesity-in-
duced TNF-a may lead to an increase in CTRP1 expression
in obese Zucker rats.
Resistin is one of the adipokines that is regulated by LPS. Its
mRNA levels in white adipose tissue are increased in rats that
have been treated with LPS and in 3T3-L1 adipocytes, after
treatment with LPS alone [24]. The induction of leptin mRNA
in adipose tissue is also induced by IL-1b and/or TNF-a [30],
representative proinﬂammatory cytokines that are upregulated
by LPS. Contrary to resistin, LPS did not directly induce
CTRP1 mRNA expression but its expression was highly in-
K.-y. Kim et al. / FEBS Letters 580 (2006) 3953–3960 3959duced by a combination of TNF-a and IL-1b. TNF-a, the ﬁrst
molecular link between inﬂammation and obesity, plays multi-
functional roles in adipocytes and immune cells. It stimulates
the expression of plasminogen activator inhibitor 1 (PAI-1)
by white adipocytes, leading to an increased cardiovascular
risk in obese subjects [31], increases lipolysis [32], reduces the
expression of adiponectin and resistin, and induces caspase
3-dependent adipocytes apoptosis [31,33,34]. In immune cells,
TNF-a transduces signals of survival, diﬀerentiation, and
death via its receptors TNFRI/p55/p60 and TNFRII/p75/p80
[35,36] and elicits diverse biological consequences by inducing
the expression of various genes that are regulated by NF-jB,
which regulate the expression of genes that are involved in
inﬂammation, cell cycle regulation, immune responses via the
expression of cytokines [37]. Therefore, the secretory protein
CTRP1 induced by TNF-a might play an important role in
at least one of the obesity and immune system functions that
are mediated by TNF-a.
In conclusion, CTRP1, a member of the CTRP superfamily,
is highly expressed in adipose tissues of Zucker diabetic fatty
(fa/fa) rats and SD rats that have been treated with TNF-a
and IL-1b. These results suggest that CTRP1 may play an
important role in adipocyte biology. Further studies address-
ing the function of CTRP1 will provide insights into its role
in other tissues as well as in adipose tissues.
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